3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Renal Insufficiency, Chronic
1
Renal Insufficiency
1
Lymphoma, Follicular
1
Heart Failure, Diastolic
1
Heart Failure
1
Breast Neoplasms
1
Interventions
Dexamethasone
8
Bortezomib
7
Cyclophosphamide
6
Lenalidomide
4
isatuximab
3
glucarpidase
3
Calcium Dobesilate
3
Thalidomide
2
Kidney Transplantation
2
Blood Specimen Collection
2
Bendamustine Hydrochloride
2
pomalidomide
1
gamma-Glutamyl Hydrolase
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
daratumumab
1
auricularum
1
Whole-Body Irradiation
1
Urination
1
Urinalysis
1
Stents
1
Standard of Care
1
Rituximab
1
Ranitidine
1
Nephrotomy
1
Nephrostomy, Percutaneous
1
Methotrexate
1
Leucovorin
1
Ice
1
Hematologic Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Renal Insufficiency
×
Eplerenone
×
Clear all
NCT07029503
2026-02-24
SCARF-1
Karolinska Institutet
Phase 2
Recruiting
40 enrolled